Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial-Reference-Cited by-同舟云学术

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial

Published:2019-05-28 Issue:22 Volume:139 Page:2542-2553
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Azizi Michel¹²³,Schmieder Roland E.⁴,Mahfoud Felix⁵⁶,Weber Michael A.⁷,Daemen Joost⁸,Lobo Melvin D.⁹,Sharp Andrew S.P.¹⁰,Bloch Michael J.¹¹,Basile Jan¹²,Wang Yale¹³,Saxena Manish⁹,Lurz Philipp¹⁴,Rader Florian¹⁵,Sayer Jeremy¹⁶,Fisher Naomi D.L.¹⁷,Fouassier David¹²³,Barman Neil C.¹⁸,Reeve-Stoffer Helen¹⁸,McClure Candace¹⁹,Kirtane Ajay J.²⁰,Jay Desmond,Skeik Nedaa,Schwartz Robert,Dohad Suhail,Victor Ronald,Sanghvi Kintur,Costello Josh,Walsh Courtney,Abraham Josephine,Owan Theophilus,Abraham Anu,Mauri Laura,Sobieszczky Piotr,Williams Jonathan,Roongsritong Chanwit,Todoran Thomas,Powers Eric,Hodskins Emily,Fong Pete,Laffer Cheryl,Gainer James,Robbins Mark,Reilly John,Cash Michael,Goldman Jessie,Aggarwal Sandeep,Ledley Gary,His David,Martin Scott,Portnay Edward,Calhoun David,McElderry Thomas,Maddox William,Oparil Suzanne,Huang Pei-Hsiu,Jose Powell,Khuddus Matheen,Zentko Suzanne,O’Meara James,Barb Ilie,Garasic Joseph,Drachman Doug,Zusman Randy,Rosenfield Kenneth,Devireddy Chandan,Lea Janice,Wells Bryan,Stouffer Rick,Hinderliter Alan,Pauley Eric,Potluri Srinivasa,Biedermann Scott,Bangalore Sripal,Williams Stephen,Zidar David,Shishehbor Mehdi,Effron Barry,Costa Marco,Radhakrishnan Jai,Mathur Anthony,Jain Ajay,Iyer Sudha Ganesh,Robinson Nicholas,Edroos Sadat Ali,Levy Terry,Patel Amit,Beckett David,Bent Clare,Davies Justin,Chapman Neil,Shin Matthew Shun,Howard James,Joseph Anil,D’Souza Richard,Gerber Robert,Faris Mohamad,Marshall Andrew John,Elorz Cristina,Höllriegel Robert,Fengler Karl,Rommel Karl-Philipp,Böhm Michael,Ewen Sebastian,Lucic Jelena,Ott Christian,Schmid Axel,Uder Michael,Rump Christian,Stegbauer Johannes,Kröpil Patric,Sapoval Marc,Cornu Erika,Lorthioir Aurélien,Gosse Philippe,Cremer Antoine,Trillaud Hervé,Papadopoulos Panteleimon,Pathak Atul,Honton Benjamin,Lantelme Pierre,Berge Constance,Courand Pierre-Yves,Feyz Lida,Blankestijn Peter,Voskuil Michiel,Rittersma Zwaantina,Kroon A.A.,van Zwam W.H.,Persu Alexandre,Renkin Jean,

Affiliation:

1. Université Paris-Descartes, France (M.A., D.F.).

2. AP-HP, Department of Hypertension, Hôpital Européen Georges-Pompidou, Paris, France (M.A., D.F.).

3. INSERM, CIC1418, Paris, France (M.A., D.F.).

4. Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University, Germany (R.E.S.).

5. Klinik für Innere Medizin III, Saarland University Hospital, Homburg/Saar, Germany (F.M.).

6. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge (F.M.).

7. Division of Cardiovascular Medicine, State University of New York, Downstate Medical Center, New York (M.A.W.).

8. Erasmus MC, University Medical Center Rotterdam, Department of Cardiology, Rotterdam, The Netherlands (J.D.).

9. Barts NIHR Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.D.L., M.S.).

10. Royal Devon and Exeter NHS Foundation Trust, United Kingdom (A.S.P.S.).

11. Department of Medicine, University of Nevada School of Medicine, Vascular Care, Renown Institute of Heart and Vascular Health, Reno, NV (M.J.B.).

12. Seinsheimer Cardiovascular Health Program, Medical University of South Carolina, Ralph H Johnson VA Medical Center, Charleston (J.B.).

13. Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis (Y.W.).

14. Heart Center Leipzig, University of Leipzig, Germany (P.L.).

15. Cedars-Sinai Heart Institute, Los Angeles, CA (F.R.).

16. The Essex Cardiothoracic Centre, United Kingdom (J.S.).

17. The Brigham and Women’s Hospital, Boston, MA (N.D.L.F.).

18. ReCor Medical, Inc, Palo Alto, CA (N.C.B., H.R.S.).

19. NAMSA, Minneapolis, MN (C.McC.).

20. Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, NY (A.J.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs

2. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

3. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

4. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

5. Reinnervation of Renal Afferent and Efferent Nerves at 5.5 and 11 Months After Catheter-Based Radiofrequency Renal Denervation In Sheep

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta‐Analysis;Journal of the American Heart Association;2024-08-20

2. The Current State and Future of Renal Denervation: A Review;Trends in Cardiovascular Medicine;2024-08

3. Investigations of Laser‐Assisted Renal Denervation for Treatment of Resistant Hypertension;Lasers in Surgery and Medicine;2024-07-04

4. Percutaneous renal denervation in the management of hypertension: Chinese expert scientific statement;Cardiology Plus;2024-05-22

5. Overview of the 2023 FDA Circulatory System Devices Advisory Panel meeting on the Recor Paradise Ultrasound‐Based Renal Denervation System;Catheterization and Cardiovascular Interventions;2024-05-07